It has been reported that Elt plays an important immunomodulatory role in the treatment of immune thrombocytopenic purpura (ITP), such as the decreased release of IFN-γ and improved immune balance [22–24]. Here, IFNG is linked to autoimmune thrombocytopenic purpura.